All Categories
Business
Entertainment
Health
Finance
Other
Category
Medicine and Healthcare
Press Release
Dec 12, 2024
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
Read More
Press Release
Dec 12, 2024
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
Read More
Press Release
Dec 12, 2024
Interactive Strength Inc. (Nasdaq:TRNR) Signs Exclusive Letter of Intent to Acquire Scaled and Profitable, Connected-Fitness Equipment Business
Exclusive Non-Binding Letter of Intent signed with Target that has more than $40 million in revenue and positive EBITDA in 100% equity consideration transaction Acquisition is expected to be TRNR's second transaction within 12 Months Advances strategy of using public listing to make accretive acquisitions of profitable and high-growth businesses in the highly fragmented health & wellness market globally Target's complementary product and customer footprint Expands TRNR's range of equipment and brands
Read More
Press Release
Dec 11, 2024
Electromedical Technologies Unveils Groundbreaking Details About the WellnessPro Infinity and Announces Production Timeline
Electromedical Technologies is excited to share key updates on the WellnessPro Infinity, a revolutionary device redefining the standards of pain management and wellness technology.
Read More
Press Release
Dec 11, 2024
Nature's Answer Awards $10,000 Grant to Support Local Individual Battling Breast Cancer
Nature’s Answer Continues Its Tradition of Giving: Eighth Year of Fundraising to Support the Community
Read More
Press Release
Dec 11, 2024
UK Clinicians Call for Urgent Modernization of NHS EHR Systems to Align With Global Healthcare IT Advancements, Black Book Survey Finds
The 2025 Black Book of Global Healthcare IT user polls reveal a critical need to modernize NHS EHR systems to address the baseline expectations of healthcare professionals and drive meaningful improvements in patient outcomes. Leading systems like Dedalus, Oracle Health, and Nervecentre have set new standards for satisfaction and innovation, offering the NHS valuable insights to elevate its digital health ecosystem and deliver more efficient, patient-centered care.
Read More
Press Release
Dec 11, 2024
IDTechEx Forecast the Diversifying Wearable Sensors Market to Reach US$7.2B by 2035
Read More
Press Release
Dec 11, 2024
CARDIO inCode Publication in International Journal of Cardiology Cardiovascular Risk and Prevention
Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention
Read More
Press Release
Dec 11, 2024
NLS Pharmaceutics CEO Issues Letter to Shareholders
Read More
Press Release
Dec 10, 2024
Assured Imaging Partners With Advantia Health to Bring Advanced 3D Mammography Services
Read More
Press Release
Dec 10, 2024
Growing Demand for Population Health Tools in Asia-Pacific Highlighted in the 2025 Black Book of Global Healthcare IT
As Australia, China, Japan, India and South Korea embrace digital health strategies, supportive policies and growing investments in PHM solutions are driving significant advancements in care coordination, chronic disease management, and health equity across the region.
Read More
Press Release
Dec 10, 2024
U.S. Top Medical Doctors Partner With Known Co-Founder Kourtney Simmang to Launch Kale Health: A Functional Health Innovation
Bridging functional health with top-tier medical expertise, Kale Health introduces a comprehensive, client-centered approach to modern care.
Read More
Press Release
Dec 10, 2024
Echo IQ Signs Integration Agreement With Flagship US Hospital
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA
Read More
Press Release
Dec 10, 2024
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
Read More
Press Release
Dec 10, 2024
Medical Pioneer Dr. Vinson Eugene Allen Celebrated and Honored With Key to City of Compton
The City of Compton Pays Tribute to Dr. Vinson Eugene Allen
Read More
Press Release
Dec 10, 2024
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ Submits FDA Investigational New Drug Application for Cannabis-Derived Drug
Read More
Press Release
Dec 10, 2024
Vheda Health Achieves I1 HITRUST Certification
Reinforcing Its Commitment to Security and Client Trust
Read More
Press Release
Dec 10, 2024
Tallahassee Plastic Surgery Clinic Launches Nouvo Med Spa - Area's Newest Destination in Non-Invasive Aesthetic Care
Read More
Press Release
Dec 10, 2024
Dr. Amir Bajoghli and Team Publish New Case Study on Aquagenic Urticaria in BMJ Journals
Read More
Press Release
Dec 10, 2024
Dr. Sindhu Srinivas Joins Ankle & Foot Centers of America
A fellowship-trained ankle and foot surgeon and expert in lower-limb salvage, Srinivas will provide a comprehensive range of podiatric services and support the practice's treatment of complex lower extremity conditions.
Read More
Press Release
Dec 10, 2024
Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne
- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne - - Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 study for the treatment of acne and expects to announce topline results in March 2025 - - Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -
Read More
Press Release
Dec 10, 2024
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
~ Supply Chain Now Fully Secure for PF614-MPAR ~
Read More
Press Release
Dec 10, 2024
Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards
Read More
Press Release
Dec 9, 2024
Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting
54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and improvements in patient-reported outcomes in patients with polycythemia vera
Read More
Press Release
Dec 9, 2024
Alliant Health Solutions Announces Promotion of Dr. Natasha Avery to Chief Operating Officer
Read More
Press Release
Dec 9, 2024
Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of CTD
Read More
Press Release
Dec 9, 2024
CUTV News Welcomes Dr. Christy Soto - Johnson
Close-Up Televisions Jim Masters discusses the many ways and levels of healing people in a new video series with Dr. Christy Soto-Johnson
Read More
Press Release
Dec 9, 2024
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
Read More
Press Release
Dec 6, 2024
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
Read More
Press Release
Dec 6, 2024
Microblading PMU Removal Services Now Available at Skin & Laser Dermatology Center
Read More
Press Release
Dec 6, 2024
U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health’s Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins
The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and/or microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder, in the US, EU, and/or Middle East/North Africa (MENA) regions; availability of IIT proof-of-concept results potentially in Q2 2025 Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both SBS-IF and MVID
Read More
Press Release
Dec 5, 2024
Birdsong Health Literacy Center of Excellence Launched to Advance Health Literacy and Drive Economic Prosperity
Read More
Press Release
Dec 5, 2024
Article about Canalevia-CA1, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for the Treatment of Chemotherapy-Induced Diarrhea in Dogs, Published in PetVet Magazine
Canalevia®-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree Crofelemer, the active ingredient in Canalevia CA-1, is the subject of Jaguar's recently conducted Phase 3 OnTarget trial in humans for cancer therapy-related diarrhea
Read More
Press Release
Dec 5, 2024
Travel Nurses, Inc. Announces Their 50th Daisy Award Honoree
Kourtney Chuman, RN and Nicolette Kohler, RN were Travel Nurses, Inc.'s 49th and 50th DAISY Award honorees.
Read More
Press Release
Dec 5, 2024
Vituity Announces Enterprise-Wide Partnership With Clinical Documentation AI Leader Sayvant
Vituity and Sayvant have solidified an enterprise-wide agreement to elevate the clinician experience and streamline care delivery, setting a new standard for innovation in acute care.
Read More
Press Release
Dec 5, 2024
The Longevity Center Offering Low-Cost EBOO IV Therapy for a Wide Range of Health Conditions
Patients at the West Palm Beach health clinic get lower costs and better outcomes on EBOO and other safe and effective IV therapies
Read More
Press Release
Dec 5, 2024
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
Read More
Press Release
Dec 5, 2024
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024
Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.
Read More
Press Release
Dec 4, 2024
UDS Health and Relentless Health to Collaborate on PFAS Testing for Fire Departments
UDS Health and Relentless Health jointly announce the launch of their collaboration to bring simple, accurate PFAS testing to fire departments across the US.
Read More
Press Release
Dec 4, 2024
Curiteva Surpasses 2,000 Procedures With Inspire(R)C Cervical Trabecular PEEK(TM) With HAFUSE(R) Technology
Read More
Press Release
Dec 4, 2024
Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects
Powered by Aptevo's proprietary ADAPTIR-FLEX®platform, antibody innovation targeting difficult-to-treat cancers
Read More
Press Release
Dec 4, 2024
Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
~ $10 Million Commitment from Specialty Drug Manufacturer to Support Commercialization Efforts ~
Read More
Press Release
Dec 4, 2024
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
Read More
Press Release
Dec 4, 2024
Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing
Read More
Press Release
Dec 3, 2024
Aytu BioPharma Disclosure Notification
Read More
Press Release
Dec 3, 2024
Liom Cracks "Holy Grail" of Non-Invasive Glucose Monitoring and Secures USD >25m in Funding Kickstarting Its Series A
Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable, is thrilled to announce significant technological milestones and a successful kick-off of its Series A.
Read More
Press Release
Dec 3, 2024
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
Read More
Press Release
Dec 3, 2024
MobilityWorks Opens New Raleigh Location, Expanding Access to Mobility Solutions in North Carolina
MobilityWorks has opened a new location in the Raleigh community to provide those with limited mobility access to wheelchair accessible vehicles, services and resources.
Read More
Press Release
Dec 3, 2024
Jorie AI Achieves HITRUST R2 Certification Demonstrating the Highest Level of Information Protection Assurance
HITRUST r2 Certification validates Jorie AI is committed to strong cybersecurity and protecting sensitive data.
Read More
Press Release
Dec 3, 2024
Ascend Aesthetic Partners Marks First Year Uniting Top Surgeons in Aesthetic Care Nationwide
Read More
Press Release
Dec 3, 2024
Epworth Hospital Receives Generous Donation for Mackenzie Dinner Doctors Grants
GJK Facility Services Director George Stamas Delivers Closing Speech
Read More
Press Release
Dec 3, 2024
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
- STAR-1 topline results expected in March 2025 - - Over 30 million acne patients seek treatment in the U.S. each year - - Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -
Read More
Press Release
Dec 3, 2024
Healing Hands: The Story of Dr. Ranen and His Chiropractic Sport Experience
Read More
Press Release
Dec 3, 2024
Modular Medical Announces Conference Call to Provide Business Update
Read More
Press Release
Dec 3, 2024
Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County
Read More
Press Release
Dec 3, 2024
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
Read More
Press Release
Dec 2, 2024
Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs Canalevia®-CA1, Jaguar's first-generation antisecretory drug for the treatment of chemotherapy-induced diarrhea in dogs, has received extension of conditional approval by FDA
Read More
Press Release
Dec 2, 2024
San Diego-Based Alcohol and Drug Rehab Facility Helps Patients Restore Dignity During the Addiction Recovery Process
Read More
Press Release
Dec 2, 2024
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's disease Expanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's
Read More
Press Release
Dec 2, 2024
Park Mental Health Treatment Builds an Environment of Trust and Safety to Restore Dignity, Encourage Hope and Promote Healing for Clients
Read More
First
Prev
41
42
43
44
45
46
Next